SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Autolus Therapeutics Q1 EPS $(0.600) Beats $(0.740) Estimate

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.600) per share which beat the analyst consensus estimate of $(0.740) by 18.92 percent. This is a 13.04 percent increase over losses of $(0.690) per

Benzinga · 05/07/2020 11:25

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.600) per share which beat the analyst consensus estimate of $(0.740) by 18.92 percent. This is a 13.04 percent increase over losses of $(0.690) per share from the same period last year.